Related Experiment Videos
Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
D S Goumenos1, C B Brown, J Shortland
1Sheffield Kidney Institute, Northern General Hospital, UK.
Abstract:
The limited knowledge of the cellular mediators of renal scarring hampers progress in the management of progressive chronic renal failure (CRF). We have studied 38 patients with biopsy-proven mesangial IgA nephropathy with emphasis on attempting to define the role of myofibroblasts (alpha-smooth muscle actin/SMA-positive cells) in renal scarring. In 18 untreated patients, correlations were undertaken between known histological parameters of progression as well as the presence of myofibroblasts in tissues and the clinical outcome. alpha-SMA staining by an avidin-biotin-peroxidase method was confined to a large extent to the vascular smooth muscle cells of normal kidneys but extended to the tubulointerstitium and periglomerular space in scarred kidneys. Mild glomerular staining was also noted. The interstitial immunostain followed a similar distribution to that of interstitial type III collagen. Morphometric analysis showed the interstitial alpha-SMA staining to be a reliable histological predictor of outcome as it discriminated between progressors and non-progressors (chi 2 = 4.923, P = 0.026). The intensity of the interstitial alpha-SMA staining correlated with renal functional outcome; inversely with the reciprocal of serum creatinine slopes (r = -0.466, P < 0.025) and positively with the serum creatinine value at the end of the observation period (r = 0.704, P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Myofibroblasts, identified by alpha-smooth muscle actin (SMA), are key cellular mediators in progressive chronic renal failure (CRF). Their presence and intensity in kidney tissue predict disease progression and patient outcomes in IgA nephropathy.
Area of Science:
- Nephrology
- Cellular Biology
- Histopathology
Background:
- Limited understanding of cellular mediators in renal scarring hinders chronic renal failure (CRF) management.
- IgA nephropathy is a common cause of progressive CRF, characterized by renal scarring.
Purpose of the Study:
- To investigate the role of myofibroblasts (alpha-smooth muscle actin/SMA-positive cells) in renal scarring associated with IgA nephropathy.
- To determine if myofibroblast presence and distribution correlate with disease progression and clinical outcomes.
Main Methods:
- Studied 38 patients with biopsy-proven mesangial IgA nephropathy.
- Utilized avidin-biotin-peroxidase staining for alpha-SMA.
- Performed morphometric analysis to correlate interstitial alpha-SMA staining with clinical outcomes and renal function parameters.
Main Results:
- Alpha-SMA staining extended to the tubulointerstitium and periglomerular space in scarred kidneys, unlike normal kidneys.
- Interstitial alpha-SMA staining was a reliable histological predictor, discriminating between progressors and non-progressors (chi 2 = 4.923, P = 0.026).
- Interstitial alpha-SMA intensity correlated inversely with reciprocal serum creatinine slopes (r = -0.466, P < 0.025) and positively with end-period serum creatinine (r = 0.704, P < 0.001).
Conclusions:
- Myofibroblasts are significant cellular mediators in the pathogenesis of renal scarring in IgA nephropathy.
- Interstitial alpha-SMA staining is a valuable prognostic marker for predicting disease progression and renal functional decline in patients with IgA nephropathy.